Skip to content

Effect of acupressure on severity of pruritus, quality of life, and laboratory parameters in hemodialysis patients

Randomised Clinical Trial of Effect of acupressure of points SP6,SP10,ST36,LI-11 on uremic pruritus, quality of life, and laboratory parameters in hemodialysis patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017041917546N8
Enrollment
90
Registered
2017-07-05
Start date
2017-06-16
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodialysis. Extracorporeal dialysis

Interventions

Intervention 1: Intervention group 1: In this group intervention will be done three times a week during dialysis. A one-minute pressure amount of 4 (kg) will be applied on SP6, SP10, ST36, LI-11 point
Intervention group 1: In this group intervention will be done three times a week during dialysis. A one-minute pressure amount of 4 (kg) will be applied on SP6, SP10, ST36, LI-11 points by the researc
Intervention group2: In this intervention group, pressure will be applied in sham-control points that are 1-2 centimeter far from major points with similar technique and duration.

Sponsors

Vice Chancellor for Research of Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: The patients Must be on dialysis for at least 6 months; Their age should be in range of 18 to 65 years; Having itching at least for 3 months; Must be on dialysis at least three times a week for 3-4 hours; Should have intact sense in acupressure points. Exclusion criteria: The patient declines to cooperate; There is wound at acupressure points; Suffering from viral hepatitis or AIDS, Being hospitalized in the last month; Having any surgery; amputation or neuropathy in the last three months; Having history of non uremic itching, liver disease, cancer, psychiatric disorder and current infection.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Uremic pruritus. Timepoint: Before. The end of the second week and the end of the fifth week after beginning the intervention. Method of measurement: 5-D Pruritus Scale.;Quality of Life. Timepoint: Before and the end of fifth week after beginning the intervention. Method of measurement: Quality of Life Questionnaire in patients with pruritus (Itchy QoL).;Biochemical parameters including hemoglobin, hematocrit, phosphorus, calcium, sodium, potassium, PTH, BUN, and Cr. Timepoint: Before and the end of fifth week after beginning the intervention. Method of measurement: Blood sample.

Secondary

MeasureTime frame
-. Timepoint: -. Method of measurement: -.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Marzieh Momennasab

Hazrate Fateme nursing and midwifery school

momennasab@sums.ac.ir+98 71 3647 4254

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026